These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Topical administration of cyclosporin in psoriasis vulgaris]. Bunse T; Schulze HJ; Mahrle G Z Hautkr; 1990 Jun; 65(6):538, 541-2. PubMed ID: 2202163 [TBL] [Abstract][Full Text] [Related]
4. Therapy of dermatologic disease with cyclosporin A. Brown MD; Gupta AK; Ellis CN; Rocher LL; Voorhees JJ Adv Dermatol; 1989; 4():3-27; discussion 28. PubMed ID: 2701795 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of topical calcitriol 3 microg/g ointment, a new topical therapy for chronic plaque psoriasis. Kircik L J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s9-16. PubMed ID: 19702031 [TBL] [Abstract][Full Text] [Related]
6. Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies. Lebwohl M; Menter A; Weiss J; Clark SD; Flores J; Powers J; Balin AK; Kempers S; Glinert RJ; Fleming T; Liu Y; Graeber M; Pariser DM J Drugs Dermatol; 2007 Apr; 6(4):428-35. PubMed ID: 17668541 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the therapeutic range of whole blood cyclosporin concentration in the treatment of psoriasis. Ieiri I; Nakayama J; Murakami H; Hori Y; Higuchi S Int J Clin Pharmacol Ther; 1996 Mar; 34(3):106-11. PubMed ID: 8705088 [TBL] [Abstract][Full Text] [Related]
8. Topical paricalcitol (19-nor-1 alpha,25-dihydroxyvitamin D2) is a novel, safe and effective treatment for plaque psoriasis: a pilot study. Durakovic C; Ray S; Holick MF Br J Dermatol; 2004 Jul; 151(1):190-5. PubMed ID: 15270890 [TBL] [Abstract][Full Text] [Related]
9. Long-term safety and efficacy of high-concentration (20 microg/g) tacalcitol ointment in psoriasis vulgaris. Miyachi Y; Ohkawara A; Ohkido M; Harada S; Tamaki K; Nakagawa H; Hori Y; Nishiyama S Eur J Dermatol; 2002; 12(5):463-8. PubMed ID: 12370136 [TBL] [Abstract][Full Text] [Related]
10. Update on topical cyclosporin A. Background, immunology, and pharmacology. Belin MW; Bouchard CS; Phillips TM Cornea; 1990 Jul; 9(3):184-95. PubMed ID: 2197063 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris. Kragballe K; Noerrelund KL; Lui H; Ortonne JP; Wozel G; Uurasmaa T; Fleming C; Estebaranz JL; Hanssen LI; Persson LM Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905 [TBL] [Abstract][Full Text] [Related]
12. A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction. Papp KA; Tyring S; Lahfa M; Prinz J; Griffiths CE; Nakanishi AM; Zitnik R; van de Kerkhof PC; Melvin L; Br J Dermatol; 2005 Jun; 152(6):1304-12. PubMed ID: 15948997 [TBL] [Abstract][Full Text] [Related]
13. Calcipotriol ointment versus cream in psoriasis vulgaris. Duweb G; Aldebani S; Elzorghany A; Benghazil M; Alhaddar J Int J Clin Pharmacol Res; 2003; 23(2-3):47-51. PubMed ID: 15018018 [TBL] [Abstract][Full Text] [Related]
14. Clinical assessment of patients with recalcitrant psoriasis in a randomized, observer-blind, vehicle-controlled trial using indigo naturalis. Lin YK; Chang CJ; Chang YC; Wong WR; Chang SC; Pang JH Arch Dermatol; 2008 Nov; 144(11):1457-64. PubMed ID: 19015420 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of topical treatment in psoriasis with MC903, a new vitamin D analogue. Staberg B; Roed-Petersen J; Menné T Acta Derm Venereol; 1989; 69(2):147-50. PubMed ID: 2564233 [TBL] [Abstract][Full Text] [Related]
16. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis. Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961 [TBL] [Abstract][Full Text] [Related]
17. Inefficacy of topical thyroid hormone analogue TriAc in plaque psoriasis: results of a double-blind placebo-controlled trial. Vahlquist A; Törmä H; Carlsson B Br J Dermatol; 2004 Aug; 151(2):489-91. PubMed ID: 15327560 [TBL] [Abstract][Full Text] [Related]
18. Effects of oral versus topical administration of cyclosporine on phorbol ester promotion of murine epidermal carcinogenesis. Yokota K; Gill TJ; Shinozuka H Cancer Res; 1989 Aug; 49(16):4586-90. PubMed ID: 2501029 [TBL] [Abstract][Full Text] [Related]
19. A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis. Hingorani M; Moodaley L; Calder VL; Buckley RJ; Lightman S Ophthalmology; 1998 Sep; 105(9):1715-20. PubMed ID: 9754182 [TBL] [Abstract][Full Text] [Related]
20. Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial. Liao YH; Chiu HC; Tseng YS; Tsai TF Br J Dermatol; 2007 Nov; 157(5):1005-12. PubMed ID: 17935517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]